Cross Ref (Unique DOI assigned to each published article)
Cross Ref (Unique DOI assigned to each published article)
Edelweiss Pharma Analytica
Acta is a double blind peer reviewed Open Access journal that aims to publish most complete and reliable
source of information on the findings and current developments in the form of case
reports, original research and review articles, and short communications and making them freely available to everyone
immediately after publication.
Branches
of pharmaceutics includes advances in pharmaceutical analytical methods, air
analysis, chemical analysis, Competitive analysis of drugs, Drug analysis, Pharmaceutical
analysis, Pharmaceutical analytical market, Pharmaceutical analytical
market, Pharmaceutical technology, Pharmaceutical formulation, Pharmaceutics,
Quality assurance in pharmaceutical analysis, Spectrometry, Validation.
Edelweiss Pharma Analytica Acta is the Journal maintained by Edelweiss publications, which ensures of Rapid Peer review with the help of its
Editorial Board.
Authors
may submit their valuable research at: edelweisspublications@gmail.com
Edelweiss
Pharma Analytica Acta follows
peer-review process and upon acceptance of article under review process, the
article processing fee 500USD is charged accordingly to publish and make it
available to all the levels of scientific community without any hassle.
Editorial Board
The Journal Edelweiss Pharma Analytica Acta consists of Editorial Board members from all
over the world who help us in rapid peer review process (4-6 weeks).
Alain
L Fymat, Professor, International Institute of Medicine and Science, USA
Cody
P Coyne, Professor, Molecular Pharmacology and Immunology, Department of Basic
Sciences, Mississippi State University, USA
Robert
P Bianchi, President and Chief of Scientific and Technical Affairs, Prescription
Drug, Research Center, Chicago, USA
